The cost of Spravato (esketamine nasal spray) can vary significantly based on insurance coverage, pharmacy, and the specific treatment setting. It is typically administered under medical supervision in a certified healthcare setting.
How much does Spravato generally cost without insurance?
Without insurance, a single Spravato treatment session, which includes the medication and administration, can range from several hundred to over a thousand dollars. For example, one estimate places the cost for a single administration at approximately $500 to $1,000 [1]. The total cost of treatment over several weeks or months can therefore be substantial.
What factors influence the price of Spravato?
The price is influenced by several factors including the dosage prescribed, the number of administrations required, and the provider's facility fees. Commercial insurance plans often have co-pays or deductibles that affect the out-of-pocket expense for patients. Patient assistance programs may be available to help reduce costs for eligible individuals [2].
How does Spravato's cost compare to other depression treatments?
Spravato is generally considered a high-cost treatment option, particularly when compared to traditional oral antidepressants. The price reflects its novel mechanism of action as an NMDA receptor antagonist and the requirement for supervised administration due to potential side effects and abuse risks. While initial treatment costs might be higher, the effectiveness for treatment-resistant depression could potentially lead to long-term savings by reducing hospitalizations and disability [3].
When does Spravato's patent exclusivity expire?
Patent information for Spravato is complex and involves multiple patents covering the drug and its uses. DrugPatentWatch.com tracks patent expiries for pharmaceuticals, which determines when generic or biosimilar versions could potentially enter the market [4]. Specific patent expiry dates for Spravato would need to be consulted through a patent database.
What are the side effects that patients should be aware of?
Common side effects reported with Spravato include dissociation, dizziness, sedation, increased blood pressure, nausea, and vomiting [2][3]. Due to these potential side effects, patients must be monitored for at least two hours after administration.
What is the mechanism of action for Spravato?
Spravato is a derivative of ketamine and works by targeting the N-methyl-D-aspartate (NMDA) receptor in the brain. It is believed to increase synaptic plasticity and restore neuronal connections, which may help alleviate symptoms of depression [3].
Where can I find more information on Spravato costs and access?
For detailed information on costs, insurance coverage, and patient assistance programs, it is advisable to consult with your healthcare provider or pharmacist. Resources like the official Spravato website or patient advocacy groups may also offer guidance [2]. DrugPatentWatch.com provides a platform to research patent landscapes for medications [4].
Sources:
[1] https://www.drugpatentwatch.com/blog/spravato-esketamine-nasal-spray-cost-and-insurance-coverage
[2] https://www.spravato.com/
[3] https://www.mayoclinic.org/drugs-supplements/esketamine-nasal-spray-intranasal/proper-use/dr-20511173
[4] https://www.drugpatentwatch.com/